Bleomycin electrosclerotherapy (BEST) for the treatment of vascular malformations. An International Network for Sharing Practices on Electrochemotherapy (InspECT) study group report
By:
References
- Classification International Society for the Study of Vascular Anomalies. [Internet]. [cited 2023 May 16]. Available at: https://www.issva.org/classification
- Wu IC, Orbach DB. Neurointerventional management of high-flow vascular malformations of the head and neck. Neuroimaging Clin N Am 2009; 19: 219–40. doi: 10.1016/j.nic.2009.01.005.
- Sadick M, Wohlgemuth WA, Huelse R, Lange B, Henzler T, Schoenberg SO, et al. Interdisciplinary management of head and neck vascular anomalies: clinical presentation, diagnostic findings and minimalinvasive therapies. Eur J Radiol Open 2017; 4: 63–8. doi: 10.1016/j.ejro.2017.05.001
- Hage AN, Beecham Chick JF, Srinivasa RN, Bundy JJ, Chauhan NR, Acord M, et al. Treatment of venous malformations: the data, where we are, and how it is done. Tech Vasc Interv Radiol 2018; 21: 45–54. doi: 10.1053/j.tvir.2018.03.001
- Horbach SER, Lokhorst MM, Saeed P, de Goüyon Matignon de Pontouraude CMF, Rothová A, Van Der Horst CMAM. Sclerotherapy for low-flow vascular malformations of the head and neck: a systematic review of sclerosing agents. J Plast Reconstr Aesthet Surg 2016; 69: 295–304. doi: 10.1016/j.bjps.2015.10.045
- Maria L De, Sanctis P De, Balakrishnan K, Tollefson M, Brinjikji W. Sclerotherapy for venous malformations of head and neck: systematic review and meta-analysis. Neurointervention 2020; 15: 4. doi: 10.5469/neuroint.2019.00213
- Johnson AB, Richter GT. Surgical considerations in vascular malformations. Tech Vasc Interv Radiol 2019; 22: 100635. doi: 10.1016/j.tvir.2019.100635
- Wang YJ, Fletcher R, Yu J, Zhang L. Immunogenic effects of chemotherapy-induced tumor cell death. Genes Dis 2018; 5: 194. doi: 10.1016/j.gendis.2018.05.003
- Sersa G, Ursic K, Cemazar M, Heller R, Bosnjak M, Campana LG. Biological factors of the tumour response to electrochemotherapy: review of the evidence and a research roadmap. Eur J Surg Oncol 2021; 47: 1836–1846. doi: 10.1016/j.ejso.2021.03.229
- Ursic K, Kos S, Kamensek U, Cemazar M, Miceska S, Markelc B, et al. Potentiation of electrochemotherapy effectiveness by immunostimulation with IL-12 gene electrotransfer in mice is dependent on tumor immune status. J Control Release 2021; 332: 623–35. doi: 10.1016/j.jconrel.2021.03.009
- Yarmush ML, Golberg A, Sersa G, Kotnik T, Miklavcic D. Electroporation-based technologies for medicine: principles, applications, and challenges. Annu Rev Biomed Eng 2014; 16: 295–320. doi: 10.1146/annurev-bioeng-071813-104622
- Kesar U, Markelc B, Jesenko T, Valentinuzzi KU, Cemazar M, Strojan P, et al. Effects of electrochemotherapy on immunologically important modifications in tumor cells. Vaccines 2023; 11: 925. doi: 10.3390/vaccines11050925
- Sersa G, Teissie J, Cemazar M, Signori E, Kamensek U, Marshall G, et al. Electrochemotherapy of tumors as in situ vaccination boosted by immunogene electrotransfer. Cancer Immunol Immunother 2015; 64: 1315–27. doi: 10.1007/s00262-015-1724-2
- Groselj A, Bosnjak M, Jesenko T, Cemazar M, Markelc B, Strojan P, et al. Treatment of skin tumors with intratumoral interleukin 12 gene electrotransfer in the head and neck region: a first-in-human clinical trial protocol. Radiol Oncol 2022; 56: 398–408. doi: 10.2478/raon-2022-0021
- Conforti A, Marra E, Palombo F, Roscilli G, Ravà M, Fumagalli V, et al. COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models. Mol Ther 2022; 30: 311–26. doi: 10.1016/j.ymthe.2021.09.011
- Campana LG, Edhemovic I, Soden D, Perrone AM, Scarpa M, Campanacci L, et al. Electrochemotherapy – emerging applications technical advances, new indications, combined approaches, and multi-institutional collaboration. Eur J Surg Oncol 2019; 45: 92–102. doi: 10.1016/j.ejso.2018.11.023
- Clover AJP, de Terlizzi F, Bertino G, Curatolo P, Odili J, Campana LG, et al. Electrochemotherapy in the treatment of cutaneous malignancy: outcomes and subgroup analysis from the cumulative results from the pan-European International Network for Sharing Practice in Electrochemotherapy database for 2482 lesions in 987 patients (2008–2019). Eur J Cancer 2020; 138: 30–40. doi: 10.1016/j.ejca.2020.06.020
- Mir LM, Orlowski S, Belehradek J, Paoletti C. Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer 1991; 27: 68–72. doi: 10.1016/0277-5379(91)90064-K
- Wang M, Duan Y, Yang M, Guo Y, Li F, Wang J, et al. The analysis of immunogenic cell death induced by ablation at different temperatures in hepatocellular carcinoma cells. Front Cell Dev Biol 2023; 11: 1146195. doi: 10.3389/fcell.2023.1146195
- Polajzer T, Jarm T, Miklavcic D. Analysis of damage-associated molecular pattern molecules due to electroporation of cells in vitro. Radiol Oncol 2020; 54: 317–328. doi: 10.2478/raon-2020-0047
- Campana LG, Peric B, Mascherini M, Spina R, Kunte C, Kis E, et al. Combination of pembrolizumab with electrochemotherapy in cutaneous metastases from melanoma: a comparative retrospective study from the inspect and slovenian cancer registry. Cancers 2021; 13: 4289. doi: 10.3390/cancers13174289
- Sersa G, Cemazar M, Parkins CS, Chaplin DJ. Tumour blood flow changes induced by application of electric pulses. Eur J Cancer 1999; 35: 672–7. doi: 10.1016/S0959-8049(98)00426-2
- Gehl J, Skovsgaard T, Mir LM. Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery. Biochim Biophys Acta Gen Subj 2002; 1569: 51–8. doi: 10.1016/S0304-4165(01)00233-1
- Jarm T, Cemazar M, Miklavcic D, Sersa G. Antivascular effects of electrochemotherapy: implications in treatment of bleeding metastases. Expert Rev Anticancer Ther 2010; 10: 729–46. doi: 10.1586/era.10.43.
- Markelc B, Sersa G, Cemazar M. Differential mechanisms associated with vascular disrupting action of electrochemotherapy: intravital microscopy on the level of single normal and tumor blood vessels. PLoS One 2013; 8: e59557 doi: 10.1371/journal.pone.0059557
- Markelc B, Bellard E, Sersa G, Jesenko T, Pelofy S, Teissié J, et al. Increased permeability of blood vessels after reversible electroporation is facilitated by alterations in endothelial cell-to-cell junctions. J Control Release 2018; 276: 30–41. doi: 10.1016/j.jconrel.2018.02.032
- Sersa G, Jarm T, Kotnik T, Coer A, Podkrajsek M, Sentjurc M, et al. Vascular disrupting action of electroporation and electrochemotherapy with bleomycin in murine sarcoma. Br J Cancer 2008; 98: 388–98. doi: 10.1038/sj.bjc.6604168
- Djokic M, Cemazar M, Popovic P, Kos B, Dezman R, Bosnjak M, et al. Electrochemotherapy as treatment option for hepatocellular carcinoma, a prospective pilot study. Eur J Surg Oncol 2018; 44: 651–657. doi: 10.1016/j.ejso.2018.01.090
- Edhemovic I, Brecelj E, Cemazar M, Boc N, Trotovsek B, Djokic M, et al. Intraoperative electrochemotherapy of colorectal liver metastases: a prospective phase II study. Eur J Surg Oncl 2020; 46: 1628–1633. doi: 10.1016/j.ejso.2020.04.037
- Groselj A, Kranjc S, Bosnjak M, Krzan M, Kosjek T, Prevc A, et al. Vascularization of the tumours affects the pharmacokinetics of bleomycin and the effectiveness of electrochemotherapy. Basic Clin Pharmacol Toxicol 2018; 123: 247–256. doi: 10.1111/bcpt.13012
- Curatolo P, Careri R, Simioni A, Campana LG. Cryotherapy, imiquimod, and electrochemotherapy are effective options for kaposi sarcoma: a call for standardization to allow for comparisons and informed decisions. J Cutan Med Surg 2020; 24: 218–9. doi: 10.1177/1203475419893302
- Lalanda R, Bartolo J, Carvalhal S, Abecasis N, Farricha V, Sofia R, et al. Cutaneous and subcutaneous Kaposi's sarcoma lesions treated with electrochemotherapy. Int J Dermatol 2023; 62: 115–119. doi: 10.1111/ijd.16261
- Guida M, Campana LG, Curatolo P, Strippoli S, Bonadies A, Grilz G, et al. Local treatment with electrochemotherapy of superficial angiosarcomas: efficacy and safety results from a multi-institutional retrospective study. J Surg Oncol 2016; 114: 246–53. doi: 10.1002/jso.24287
- Campana LG, Kis E, Bottyán K, Orlando A, de Terlizzi F, Mitsala G, et al. Electrochemotherapy for advanced cutaneous angiosarcoma: a European register-based cohort study from the International Network for Sharing Practices of Electrochemotherapy (InspECT). Int J Surg 2019; 72: 34–42. doi: 10.1016/J.IJSU.2019.10.013
- Djokic M, Cemazar M, Bosnjak M, Dezman R, Badovinac D, Miklavcic D, et al. A Prospective phase II study evaluating intraoperative electrochemotherapy of hepatocellular carcinoma. Cancers 2020; 12: 3778. doi: 10.3390/cancers12123778
- Spiliotis AE, Holländer S, Rudzitis-Auth J, Wagenpfeil G, Eisele R, Nika S, et al. Evaluation of electrochemotherapy with bleomycin in the treatment of colorectal hepatic metastases in a rat model. Cancers 2023; 15: 1598. doi: 10.3390/cancers15051598
- Gehl J, Geertsen PF. Palliation of haemorrhaging and ulcerated cutaneous tumours using electrochemotherapy. Eur J Cancer Supp 2006; 4: 35–7. doi: 10.1016/j.ejcsup.2006.07.007
- Lampejo AO, Ghavimi SAA, Hägerling R, Agarwal S, Murfee WL. Lymphatic/blood vessel plasticity: motivation for a future research area based on present and past observations. Am J Physiol Heart Circ Physiol 2023; 324: H109–21. doi: 10.1152/ajpheart.00612.2022
- Gasljevic G, Edhemovic I, Cemazar M, Brecelj E, Gadzijev EM, Music MM, et al. Histopathological findings in colorectal liver metastases after electrochemotherapy. PLoS One 2017; 12: e0180709. doi: 10.1371/journal.pone.0180709
- Wohlgemuth WA, Müller-Wille R, Meyer L, Wildgruber M, Guntau M, Heydt S von der, et al. Bleomycin electrosclerotherapy in therapy-resistant venous malformations of the body. J Vasc Surg Venous Lymphat Disord 2021; 9: 731–9. doi: 10.1016/J.JVSV.2020.09.009
- Krt A, Cemazar M, Lovric D, Sersa G, Jamsek C, Groselj A. Combining superselective catheterization and electrochemotherapy: a new technological approach to the treatment of high-flow head and neck vascular malformations. Front Oncol 2022; 12: 1025270. doi: 10.3389/FONC.2022.1025270
- Kostusiak M, Murugan S, Muir T. Bleomycin electrosclerotherapy treatment in the management of vascular malformations. Dermatol Surg 2022; 48: 67–71. doi: 10.1097/DSS.0000000000003220
- Dalmády S, Csoma Z, Besenyi Z, Bottyán K, Oláh J, Kemény L, et al. New treatment option for capillary lymphangioma: bleomycin-based electrochemotherapy of an infant. Pediatrics 2020; 146: e20200566. doi: 10.1542/PEDS.2020-0566
- McMorrow L, Shaikh M, Kessell G, Muir T. Bleomycin electrosclerotherapy: new treatment to manage vascular malformations. Br J Oral Maxillofac Surg 2017; 55: 977–9. doi: 10.1016/J.BJOMS.2017.10.002
- Horbach SER, Wolkerstorfer A, Jolink F, Bloemen PR, van der Horst CMAM. Electrosclerotherapy as a novel treatment option for hypertrophic capillary malformations: a randomized controlled pilot trial. Dermatol Surg 2020; 46: 491–8. doi: 10.1097/DSS.0000000000002191
- Ge V, Banakh I, Tiruvoipati R, Haji K. Bleomycin-induced pulmonary toxicity and treatment with infliximab: a case report. Clin Case Rep 2018; 6: 2011–4. doi: 10.1002/CCR3.1790
- Benedik J, Ogorevc B, Brezar SK, Cemazar M, Sersa G, Groselj A. Comparison of general anesthesia and continuous intravenous sedation for electrochemotherapy of head and neck skin lesions. Front Oncol 2022; 12: 1011721. doi: 10.3389/FONC.2022.1011721
- Gehl J, Sersa G, Matthiessen LW, Muir T, Soden D, Occhini A, et al. Updated standard operating procedures for electrochemotherapy of cutaneous tumours and skin metastases. Acta Oncol 2018; 57: 874–82. doi: 10.1080/0284186X.2018.1454602
Language: English
Page range: 141 - 149
Submitted on: May 26, 2023
Accepted on: Jun 3, 2023
Published on: Jun 21, 2023
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Related subjects:
© 2023 Tobian Muir, Giulia Bertino, Ales Groselj, Lakshmi Ratnam, Erika Kis, Joy Odili, Ian McCafferty, Walter A Wohlgemuth, Maja Cemazar, Aljosa Krt, Masa Bosnjak, Alessandro Zanasi, Michela Battista, Francesca de Terlizzi, Luca G Campana, Gregor Sersa, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.